Kiyoshi Nokihara |  Diagnostic Analytics | Pioneer Researcher Award

Prof. Dr. Kiyoshi Nokihara |  Diagnostic Analytics | Pioneer Researcher Award

Hipep Laboratories | Japan

Kiyoshi Nokihara is a distinguished biomedical scientist whose career spans organic chemistry, peptide-protein science and bio-detection instrumentation. After his initial studies in Tokyo, he conducted research in Germany at the Deutsches Wollforschungs­institut an der Technischen Hochschule Aachen (1974-79) focusing on the chemistry and biology of biomolecules such as insulin, followed by work in the U.S. with Finnegan Inc. in Silicon Valley on mass spectrometry of biomolecules. He returned to Japan to investigate brain-gastrointestinal and neuro-peptides as Assistant Professor at the Shizuoka Prefectural University. Subsequent roles included Visiting Professor at the University of Heidelberg (via the Alexander von Humboldt Foundation) and R&D leadership at Shimadzu Corporation leading the Life Science Center, where his team received a national award from the Japanese Agency of Science and Technology. In 2002 he founded HiPep Laboratories as CEO & CSO to develop novel biodetection systems, and since 2017 he holds a Professor position at the First School of Clinical Medicine, First Affiliated Hospital, Nanjing Medical University (China). With over 119 publications, more than ~3,365 citations (according to ResearchGate) and numerous patent applications (130+), his research interests include peptide-protein recognition, structural biology, combinatorial chemistry, immunochemistry, instrumentation and drug-discovery technologies. His work has been recognized by multiple awards and national projects for innovation in life-science instrumentation and biomedical applications. In sum, Dr. Nokihara’s career bridges academic discovery, applied instrumentation and entrepreneurial innovation in peptide/bio-molecular sciences.

Profile : Scopus

Featured Publications

Kiyoshi Nokihara (2025). Development of a new biodetection system independent of known marker molecules using a novel material for microarrays made from amorphous carbon substrates. Analytical Methods.

Kiyoshi Nokihara. Construction of cyclic peptide libraries immobilized on gel-type supports for screening towards discovery of interacting peptides. Book Chapter.

Kiyoshi Nokihara (2024). A high-throughput sequence determination for one cyclic peptide immobilized on a single bead by the one-pot cyanidation followed by MALDI-TOF–MS/MS for discovery of interacting peptides. Analytical Sciences.

Kiyoshi Nokihara (2023). A novel cyclic peptide library immobilized on gel-type beads focusing on rapid construction and characterization for comprehensive drug discovery. Chemical Biology and Drug Design.

Kiyoshi Nokihara (2022). Investigation of the behaviors of molecules exhibiting angiogenic actions. International Journal of Peptide Research and Therapeutics.

Kiyoshi Nokihara (2020). Improved design of peptides exhibiting angiogenic activities for clinical applications. Bioorganic and Medicinal Chemistry.

Bindhu Omana Sukumaran | Best Researcher Award | BIOCHEMISTRY 

Bindhu Omana Sukumaran | Best Researcher Award  Winner 2023  🏆

Prof Bindhu Omana Sukumaran : BIOCHEMISTRY

Congratulations to Prof. Bindhu Omana Sukumaran for receiving the Best Researcher Award at the International Research Data Analysis Excellence Awards in the field of Biochemistry. This prestigious recognition reflects your outstanding contributions to research and dedication to advancing knowledge in the field. Well-deserved honor!

Professional profile:

Early Academic Pursuits:

I began my academic journey with a strong foundation, achieving First Class in Class X under the Board of Public Examinations, Government of Kerala, in 1990. This was followed by a Pre-Degree with First Class from the University of Kerala in 1992. Subsequently, I pursued BSc in Botany (Main) with Chemistry and Zoology as subsidiaries, graduating with Distinction in 1995 from the University of Kerala. My commitment to academic excellence continued as I pursued a Master of Science in Medical Biochemistry from MAHE (Manipal Academy of Higher Education) University, where I graduated with First Class honors in 1998.

Professional Endeavors:

My professional journey took a significant turn when I embarked on a Ph.D. in Cancer Biology (Medical Biochemistry) at the Regional Cancer Centre, Thiruvananthapuram, Kerala. I successfully defended my thesis titled "Matrix Metalloproteinases in Oral Cancer" in July 2005. This comprehensive research delved into the intricate molecular mechanisms underlying the progression of Oral Squamous Cell Carcinoma (OSCC), exploring the roles of Matrix Metalloproteinases (MMPs) and their inhibitors, Tissue Inhibitor Metalloproteinases (TIMPs).

Contributions and Research Focus:

My Ph.D. work focused on understanding the functional role and clinical significance of MMPs and TIMPs in the progressing histology of oral tissue, ranging from normal to invasive oral carcinoma. The study utilized immunohistochemistry, zymography, and Western blotting techniques, revealing a gradual increase in MMP expression and gelatinolytic activity with the histologic progression of malignancy. Moreover, my research uncovered the correlation between NFκB activation and gelatinase expression, suggesting the regulatory role of NFκB in malignant transformation.

Accolades and Recognition:

During my doctoral journey, I garnered recognition for my work, presenting posters and delivering an oral presentation at prestigious events such as the 21st Annual Convention of the Indian Association for Cancer Research and the International Workshop on Cervical Cancer. These presentations highlighted the clinical significance of gelatinases in oral cancer and the activation of NFκB during oral tumorigenesis.

Impact and Influence:

The findings from my research contribute significantly to the understanding of molecular processes underlying oral cancer progression. The correlations established between MMPs, TIMPs, and NFκB activation provide valuable insights for potential prognostic markers in oral carcinoma. The impact of my work extends to the clinical analysis of surgical margins, suggesting the evaluation of MMP and TIMP proteins as new molecular-level prognostic factors.

Legacy and Future Contributions:

My research forms a foundation for future studies in the field of cancer biology, particularly in understanding the regulatory mechanisms of MMPs and the role of NFκB in malignant transformation. The implications for clinical prognostication underscore the potential for further research in developing targeted therapies for oral carcinoma.

In conclusion, my academic journey and research endeavors reflect a commitment to excellence in understanding the molecular intricacies of oral cancer, with potential implications for clinical practice and future research initiatives.

Notable Publication:

Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review   Cited By 374 2015 year
High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma Cited By 98 2016 Year
Characterisation of potential milk coagulants from Calotropis gigantea plant parts and their hydrolytic pattern of bovine casein Cited By 62 2014 Year
Salivary glucose and antioxidant defense markers in type II diabetes mellitus Cited By 46 year 2014
Three phase partitioning to concentrate milk clotting proteases from Wrightia tinctoria R. Br and its characterization Cited By 29 Year 2018